Reference
Liam C, et al. Real-World Experience of First-Line Afatinib Treatment in Patients with EGFR Mutant Advanced Non-Small Cell Lung Cancer. Journal of Thoracic Oncology 13 (Suppl.): S998-S999 abstr. P3.15-21, No. 10, Oct 2018. Available from: URL: http://doi.org/10.1016/j.jtho.2018.08.1897 [abstract] -Malaysia
Rights and permissions
About this article
Cite this article
Afatinib. Reactions Weekly 1728, 18 (2018). https://doi.org/10.1007/s40278-018-54281-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-54281-1